New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine

Reuters2021-02-03

WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc

and German's BioNTech , the government said on Wednesday.

"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19," Prime Minister Jacinda Ardern said in a statement. "It means we can now begin preparations for the first stage in our vaccination roll-out.”

The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year.

(Reporting by Praveen Menon; editing by Jane Wardell)

((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; Twitter: ))

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

JazzyTazzy
2021-02-03
JazzyTazzy
赞！
- jezzytezzy:
  yum

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2108758903?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-02-03 09:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2108758903","market":"us","top_or_hot":-1,"title":"New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine","media":"Reuters","content":"<html><body><p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc</p><p>  and German's BioNTech   , the government said on Wednesday.</p><p>   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.” </p><p>   The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year. </p><p> (Reporting by Praveen Menon; editing by Jane Wardell)</p><p>((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: ))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-03 09:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc  and German's BioNTech   ,...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2108758903","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2108758903","pubTimestamp":1612314061,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"新西兰监管机构批准辉瑞生物技术公司COVID-19疫苗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc  and German's BioNTech   , the government said on Wednesday.   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.”    The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year.  (Reporting by Praveen Menon; editing by Jane Wardell)((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; Twitter: ))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":314106459,"gmtCreate":1612316032171,"gmtModify":1703760252561,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"赞！","listText":"赞！","text":"赞！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/314106459","repostId":2108758903,"repostType":2,"repost":{"id":"2108758903","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612314061,"share":"https://www.laohu8.com/m/news/2108758903?lang=&edition=full","pubTime":"2021-02-03 09:01","market":"us","language":"en","title":"New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2108758903","media":"Reuters","summary":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the","content":"<html><body><p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc</p><p>  and German's BioNTech   , the government said on Wednesday.</p><p>   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.” </p><p>   The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year. </p><p> (Reporting by Praveen Menon; editing by Jane Wardell)</p><p>((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: ))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-03 09:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc</p><p>  and German's BioNTech   , the government said on Wednesday.</p><p>   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.” </p><p>   The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year. </p><p> (Reporting by Praveen Menon; editing by Jane Wardell)</p><p>((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108758903","content_text":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc  and German's BioNTech   , the government said on Wednesday.   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.”    The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year.  (Reporting by Praveen Menon; editing by Jane Wardell)((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; Twitter: ))","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3475982,"gmtCreate":1612334081382,"gmtModify":1635766819997,"authorId":3567197758280595,"author":{"id":3567197758280595,"authorId":3567197758280595,"name":"jezzytezzy","avatar":"https://static.tigerbbs.com/0ef706364982b2582c9190fdc988b8ee","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":314106459,"type":1,"supId":0,"prevId":0,"content":"<u>yum</u>","text":"<u>yum</u>","html":"<u>yum</u>"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2108758903"}